Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
1980-11-20
pubmed:abstractText
The excellent properties of the new substance eprazinone-dihydrochloride (Eftapan) was demonstrated in a double-blind trial. This agent showed marked secretolytic and bronchial spasmodic properties, further antitussive action and pain relief in the bronchial system. These effects were proven with the parameters of pulmonary function. The substance didn't show any side effect.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0015-8178
pubmed:author
pubmed:issnType
Print
pubmed:day
12
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
(871-4)
pubmed:dateRevised
2009-10-19
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
[The efficacy of eprazinone dihydrochloride (Eftapan) in double-blind studies].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Controlled Clinical Trial